RADICAVA

Serial Number 86863296
Registration 5277200
702

Registration Progress

Application Filed
Dec 31, 2015
Under Examination
Aug 2, 2016
Approved for Publication
Jun 7, 2016
Published for Opposition
Jun 7, 2016
Registered
Aug 29, 2017

Trademark Image

RADICAVA

Basic Information

Serial Number
86863296
Registration Number
5277200
Filing Date
December 31, 2015
Registration Date
August 29, 2017
Published for Opposition
June 7, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 9, 2024
Registration
Registered
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
3-2-10, Dosho-machi, Chuo-ku
Osaka-shi, Osaka 541-8505
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
Osaka-shi, Osaka JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
Osaka-shi, Osaka JP

Mitsubishi Tanabe Pharma Corporation

Original Registrant
03
Osaka-shi, Osaka JP

Legal Representation

Attorney
Jeffrey L. Costellia

USPTO Deadlines

Next Deadline
757 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-08-29)
Due Date
August 29, 2027
Grace Period Ends
February 29, 2028

Application History

41 events
Date Code Type Description Documents
Feb 9, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Feb 9, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Feb 9, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 22, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 29, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 29, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 27, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 26, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 24, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 21, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 22, 2017 IUAF S USE AMENDMENT FILED Loading...
Jun 22, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 27, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 25, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 25, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 2, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 7, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 7, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 18, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 3, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
May 3, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 2, 2016 DMCC I DATA MODIFICATION COMPLETED Loading...
May 2, 2016 ALIE A ASSIGNED TO LIE Loading...
Apr 8, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 7, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 7, 2016 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 26, 2016 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 26, 2016 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Feb 26, 2016 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 12, 2016 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Feb 12, 2016 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Feb 12, 2016 CNSL R SUSPENSION LETTER WRITTEN Loading...
Feb 11, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 27, 2016 PMSD O PETITION TO DIRECTOR - MAKE SPECIAL - DENIED Loading...
Jan 25, 2016 APET A ASSIGNED TO PETITION STAFF Loading...
Jan 12, 2016 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 12, 2016 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 11, 2016 TPMS I TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED Loading...
Jan 11, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 4, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
First Use Anywhere: May 13, 2017
First Use in Commerce: May 13, 2017

Additional Information

Translation
The wording "RADICAVA" has no meaning in a foreign language.

Classification

International Classes
005